Gujarat Kidney & Super Speciality IPO: Overview

Gujarat Kidney & Super Speciality, a regional healthcare company based in Gujarat, has filed its Draft Red Herring Prospectus (DRHP) with SEBI to launch its Initial Public Offering (IPO). The IPO consists entirely of a fresh issue of 2.2 crore equity shares, with no Offer for Sale (OFS) component.

The funds raised will be utilized for strategic acquisitions, capital expenditures, and working capital requirements.

Use of IPO Proceeds

According to the DRHP, Gujarat Kidney & Super Speciality plans to allocate funds as follows:

? ₹77 crore – Acquisition of Parekhs Hospital in Ahmedabad
? ₹12.4 crore – Part-payment for Ashwini Medical Centre acquisition
? ₹30.2 crore – Capital expenditure for a new hospital in Vadodara
? ₹7.3 crore – Purchase of robotics equipment for Vadodara hospital
? ₹1.5 crore – Repayment/prepayment of secured borrowings
? Remaining funds – Unidentified acquisitions & general corporate purposes

Gujarat Kidney & Super Speciality: Company Profile

• Business Focus: Operates a chain of mid-sized multispeciality hospitals in Gujarat, providing secondary and tertiary healthcare services.

• Current Operations:

  • 6 multispeciality hospitals

  • 400 total beds (355 approved, 250 operational)

  • 3 in-house pharmacies

• Promoter & Leadership:

  • Dr. Pragnesh Yashwantsingh Bharpoda, an experienced urologist, serves as the Promoter & Managing Director.

Financial Performance (Proforma Consolidated Basis)

? Revenue from Operations:

• ₹34.01 crore (FY23) → ₹41.04 crore (FY24) ?

? Profit After Tax (PAT):

• ₹2.80 crore (FY23) → ₹4.34 crore (FY24) ?

These figures indicate steady revenue growth and improved profitability in the last fiscal year.

IPO Reservation Breakdown

? 75% of the issue is reserved for Qualified Institutional Buyers (QIBs)
? 15% is allocated to Non-Institutional Investors (NIIs)
? 10% is reserved for Retail Individual Investors (RIIs)

IPO Book-Running & Listing Details

? Lead Manager: Nirbhay Capital Services Private Limited
? Registrar: MUFG Intime India Private Limited
? Stock Exchange Listing: National Stock Exchange (NSE) & BSE

Gujarat Kidney & Super Speciality IPO Outlook

✅ Strengths:
✔ Strong regional presence in Gujarat's healthcare sector
✔ Strategic acquisitions to drive future growth
✔ Increasing revenue and profitability trends

❌ Risks:
⚠️ Highly capital-intensive industry
⚠️ Dependence on acquisitions for expansion
⚠️ Competition from larger hospital chains

Gujarat Kidney & Super Speciality’s IPO is focused on expansion through acquisitions and capital investments. Investors should closely monitor its financials, valuation, and market conditions before making a decision.

The Current active IPO are Aten Papers & Foam Limited, Infonative Solutions Limited,Spinaroo Commercial Limited,Retaggio Industries Limited.

The Closed IPOs are  Identixweb Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited, Desco Infratech Limited.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our  Read more